Form 4: GeneDx Holdings Corp: Director Joshua Ruch Reports Stock Transactions

Director Joshua Ruch reports the acquisition and disposal of Class A Common Stock and Restricted Stock Units in GeneDx Holdings Corp.

Summary

• On June 20, 2024, Joshua Ruch, a director of GeneDx Holdings Corp., reported transactions involving the company's Class A Common Stock and Restricted Stock Units (RSUs).
• Ruch acquired 5,828 shares of Class A Common Stock at $0 through the vesting of RSUs.
• Ruch also disposed of 5,828 shares of Class A Common Stock.
• Following these transactions, Ruch directly owns 7,853 shares of Class A Common Stock.
• Ruch also has indirect ownership through Kariba LLC (14,844 shares), RUGU2 LLC (30,137 shares), and VAAL Investment Partners Q9 LP (149,283 shares).
• Ruch disclaims beneficial ownership of these indirectly held securities except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: This is a neutral report on stock transactions. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Future Outlook

The RSUs shall vest the earlier of (a) the date of the next annual meeting of the Issuer's shareholders following the grant date, and (b) the first anniversary of the grant date, subject to the Reporting Person continuing to provide services to the Issuer through each vesting date.

Management Comments

• Mr. Ruch disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, which is a common practice for publicly traded companies. It provides transparency to investors regarding the trading activities of key personnel.

Stakeholder Impact

• The filing provides transparency to shareholders regarding insider trading activities.

Key Dates